ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting.
Umberto Capitanio, Giuseppe Rosiello, Andrea Necchi, Francesco Montorsi, Alessandro Larcher
Abstract readLetterComment
In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Commented on by
- Comment on
5 · Who and what moneyAuthors and funding
5 authors.
Umberto CapitanioUmberto Capitanio, MD, and Giuseppe Rosiello, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Unit of Oncology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; and Francesco Montorsi, MD, and Alessandro Larcher, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0001-9225-1795 Giuseppe RosielloUmberto Capitanio, MD, and Giuseppe Rosiello, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Unit of Oncology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; and Francesco Montorsi, MD, and Alessandro Larcher, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-4354-1582 Andrea NecchiUmberto Capitanio, MD, and Giuseppe Rosiello, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Unit of Oncology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; and Francesco Montorsi, MD, and Alessandro Larcher, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-3007-2756 Francesco MontorsiUmberto Capitanio, MD, and Giuseppe Rosiello, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Unit of Oncology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; and Francesco Montorsi, MD, and Alessandro Larcher, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
Alessandro LarcherUmberto Capitanio, MD, and Giuseppe Rosiello, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; Andrea Necchi, MD, Unit of Oncology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy; and Francesco Montorsi, MD, and Alessandro Larcher, MD, Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-5005-589X Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, Renal CellKidney NeoplasmsRenal Insufficiency, ChronicDisease ProgressionHumansRisk Factors
What OpenQuestion holds
Textmetadata
Read underepoch 390